Related Experiment Video
Updated: Aug 19, 2026
Detection of microRNA Expression in Peritoneal Membrane of Rats Using Quantitative Real-time PCR
Published on: June 27, 2017
Tissue distributions of CYP2D1, 2D2, 2D3 and 2D4 mRNA in rats detected by RT-PCR
1Laboratory of Chemistry, Osaka City University Medical School, 1-4-54, Asahimachi, Abeno-ku, Osaka 545, Japan.
Abstract:
The tissue distributions of four isoforms (CYP2D1/5, 2D2, 2D3 and 2D4/18) in rat CYP2D subfamily were investigated. Twelve kinds of tissue (liver, kidney, brain, lung, heart, spleen, adrenal gland, small intestine mucosa, bladder, testis, ovary and gonecystis) were removed from Sprague-Dawley male and female rats. The expression of CYP2D mRNA in these tissues was detected by RT-PCR. Specific primers were designed to recognize the four isoforms individually. In liver, kidney and small intestine mucosa, the mRNA expression of all four CYP2D isoforms was detected as high-intensity PCR products. mRNA of CYP2D1/5 was expressed in all tissues used in this study except the brain, although the intensity of PCR products varied among tissues. mRNAs of CYP2D2 and CYP2D3 were mainly expressed in liver, kidney and small intestine mucosa, which were exposed to xenobiotics such as drugs, food components and environmental contaminations. mRNA of CYP2D4/18 was expressed in liver, kidney, small intestine mucosa and brain. In brain, only mRNA of CYP2D4/18 was expressed. CYP2D4/18 mRNA was also expressed in ovary, testis and gonecystis. The tissue distributions help to clarify the differences in physiological and pharmacological functions between CYP2D isoforms.
Insights
This study maps the tissue distribution of four rat CYP2D isoforms. Findings reveal distinct expression patterns, particularly CYP2D4/18
Area of Science:
- Pharmacogenomics
- Biochemistry
Background:
- The cytochrome P450 (CYP) enzyme family plays a crucial role in drug metabolism.
- Understanding the tissue-specific expression of CYP isoforms is vital for predicting drug efficacy and toxicity.
- The rat CYP2D subfamily comprises several isoforms with potentially distinct physiological and pharmacological roles.
Purpose of the Study:
- To investigate the tissue distribution of four specific rat CYP2D isoforms (CYP2D1/5, 2D2, 2D3, and 2D4/18).
- To elucidate the differential expression patterns of these isoforms across various rat tissues.
- To provide insights into the functional implications of observed tissue distribution for CYP2D isoforms.
Main Methods:
- Tissue samples from twelve distinct organs were collected from male and female Sprague-Dawley rats.
- Reverse transcription polymerase chain reaction (RT-PCR) was employed to detect messenger RNA (mRNA) expression.
- Specific primers were designed for individual detection of the four CYP2D isoforms.
Main Results:
- All four CYP2D isoforms' mRNA were detected in liver, kidney, and small intestine mucosa.
- CYP2D1/5 mRNA was found in all tissues except the brain, with varying expression intensities.
- CYP2D2 and CYP2D3 mRNA were predominantly expressed in liver, kidney, and small intestine mucosa.
- CYP2D4/18 mRNA showed expression in liver, kidney, small intestine mucosa, and notably, exclusively in the brain among the tested tissues, as well as in gonads.
Conclusions:
- The distinct tissue distribution patterns of rat CYP2D isoforms suggest specialized physiological and pharmacological functions.
- CYP2D4/18's unique expression in the brain indicates a potential role in central nervous system processes or drug metabolism.
- Understanding these distributions is key to comprehending isoform-specific drug interactions and metabolic pathways.
